TARA FY 2018 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$211M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$115,000

Operating Income

-$26M

Net Income

-$25M

EPS (Diluted)

$-9.93

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$24M

Total Liabilities

$3M

Stockholders' Equity

$20M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$115,000	-$148,000	+22.3%
Operating Income	-$26M	-$30M	+14.1%
Net Income	-$25M	-$30M	+15.1%